Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor

Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

(2010) Jennifer Delli Carpini et al.   ANGIOGENESIS

BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells

(2010) K. L. Chock et al.   CANCER RESEARCH

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

(2010) Jean A. Hurteau et al.   GYNECOLOGIC ONCOLOGY

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor

(2010) Jianwei Zhou et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

The luteinizing hormone receptor: Insights into structure–function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells

(2010) David Puett et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

(2010) Björn Nodin et al.   Journal of Ovarian Research

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Follicle Stimulating Hormone Receptor in Ovarian Surface Epithelium and Epithelial Ovarian Cancer

(2008) Chinmoy K. Bose   ONCOLOGY RESEARCH

The Activity of Medroxyprogesterone Acetate, an Androgenic Ligand, in Ovarian Cancer Cell Invasion

(2008) Radhika Gogoi et al.   Reproductive Sciences